Skip to main content
. 2020 Jul 23;17:E69. doi: 10.5888/pcd17.200317

Table 1. Pharmacist Interventions and Anticipated Outcomes in Contributing to Population Healtha .

Intervention Anticipated Outcomes
Prevention
Medication monitoring
  • Provide appropriate preventive medications

  • Address medication access issues in the face of pandemic restrictions

Patient education
  • Educate patients about preventing coronavirus disease 2019 (COVID-19) infection and symptoms of the disease

  • Provide education on over-the-counter medications

  • Increase patient self-efficacy and reduce adverse outcomes from medications

Vaccinations
  • Reduce novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission when a vaccine becomes available

  • Prevent outbreaks of vaccine-preventable diseases

Point-of-care testing Increase access to COVID-19 testing and reduce transmission by early detection and quarantine of detected individuals
Management
Medication monitoring Increase treatment success
Patient education
  • Educate patients about COVID-19 disease

  • Increase patient self-efficacy and reduce adverse outcomes from medications

Medication therapy review Optimize patient medication adherence and quality of life
Disease self-care and support
  • Ensure access when medical facilities are not accepting patients

  • Empower patients, increase pharmacist role in multidisciplinary team, and improve population health

Point-of-care testing Provide real-time point of care screening results for chronic disease management
a

Based on Greer N, Bolduc J, Geurkink E, Rector T, Olson K, Koeller E, et al. Pharmacist-led chronic disease management: a systematic review of effectiveness and harms compared with usual care (7).